Marex (MRX) EBITDA (2023 - 2026)

Marex (MRX) has 4 years of EBITDA data on file, last reported at -$66.6 million in Q1 2026.

• Quarterly EBITDA fell 117.15% year-over-year to -$66.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 billion (down 19.63% YoY) and the FY2025 annual result came in at $1.2 billion, up 40.52% from the prior year.
• EBITDA fell to -$66.6 million in Q1 2026, from $1.4 billion in the prior quarter.
• In the past five years, EBITDA ranged from a high of $1.4 billion in Q4 2025 to a low of -$100.3 million in Q3 2025.
• A 4-year average of $251.9 million and a median of -$19.3 million in 2024 frame the typical range for EBITDA.
• The widest YoY moves for EBITDA: up 2482.82% in 2025, down 253.81% in 2025.
• Tracing MRX's EBITDA over 4 years: stood at -$61.8 million in 2023, then soared by 1707.12% to $993.2 million in 2024, then jumped by 41.25% to $1.4 billion in 2025, then sank by 104.75% to -$66.6 million in 2026.
• The last three EBITDA figures came in at -$66.6 million (Q1 2026), $1.4 billion (Q4 2025), and -$100.3 million (Q3 2025), per Business Quant data.